ask="6.10"
ask_size="1500"
average_daily_volume="201489"
bid="6.00"
bid_size="300"
book_value="3.24"
change="+0.10"
change_from_200_day_moving_average="-4.51"
change_from_50_day_moving_average="-0.69"
change_from_52_week_high="-11.70"
change_From_52_week_low="0.75"
change_in_percent="+1.69%"
close="6.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.50"
ebitda="-19.13M"
eps_estimate_current_year="-2.79"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-2.54"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.10"
high_52_weeks="17.70"
last_trade_date="1/9/2017"
last_trade_price="6.00"
last_trade_size="128"
last_trade_time="4:00pm"
low="5.80"
low_52_weeks="5.25"
market_capitalization="46.90M"
moving_average_200_day="10.51"
moving_average_50_day="6.69"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="5.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-42.91%"
percent_change_from_50_day_moving_average="-10.37%"
percent_change_from_52_week_high="-66.10%"
percent_change_from_52_week_low="+14.29%"
previous_close="5.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.82"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="1.46"
stock_exchange="NCM"
symbol="TRIL"
volume="70686"
weeks_range_52="5.25 - 17.70"
